Mycophenolate Mofetil in Antiretroviral Naive Patients 2 (MAN2 Study).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications HIV infections
- Focus Biomarker; Pharmacodynamics
- Acronyms MAN2
- 10 Jun 2017 Biomarkers information updated
- 17 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by Netherlands trials register.
- 17 Nov 2009 New source identified and integrated (Netherlands Trials Register; NTR428).